References
[1]任少华. 过敏性咳嗽和咳嗽变异性哮喘的比[J]. 国外医学·呼吸系统分册, 2003, 23 (1): 55.
[2]陈育智,赵京,陈坤华.全国十省市螨皮肤过敏原情况调查[J].实用诊断与治疗杂志,1994, 4(1): 301.
[3]Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E, et al. Standards for pratical allergen-specific immunotherapy[J]. Allergy, 2006, 61 (Suppl 82): 1-20.
[4]中华医学会儿科学分会呼吸学组,中华儿科杂志编辑委员会.儿童支气哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10): 745-753.
[5]全国儿科哮喘防治协作组.儿童哮喘防治常规[J].中华儿科杂志,1998,36(12):747-750.
[6]Hogg JC, James AL, Pare PD. Evidence for inflammation in asthma[J]. Am Rev Respir Dis, 1991, 143(5): S39-S42.
[7]王晋舜.咳嗽变异性哮喘诊治探讨[J].临床肺科杂志, 2006, 11(3): 369.
[8]王桂兰,鲁继荣,刘翔腾.布地耐德对哮喘模型过敏性炎症信号传导系统的干预作用[J].中国妇幼保健,2009,24 (18):2552-2554.
[9]辛建保,向敏,陶晓南,彭毅,张瑞祥.咳嗽变异性哮喘与典型哮喘患者气道高反应性的比较[J].中华医学杂志,1997,77(1):70.
[10]董宗祈,陈孝萍,袁雄伟.咳嗽变异性哮喘71例临床分析[J].中国实用儿科杂志,1996,11(6):368.
[11]Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary[J]. Eur Respir J, 2008, 31(1): 143-178.
[12]Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma[J]. J Allery Clin Immunol, 2001, 108(5 Suppl): S147-S334.
[13]Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood[J]. Allergy, 2006, 61(2): 198-201.
[14]Passalacqua G, Durham SR; Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy[J]. J Allergy Clin Immunol, 2007, 119(4): 881-891.
[15]曹兰芳, 陆权, 顾洪亮, 陈燕萍, 张源, 陆敏,等.舌下含服粉尘螨滴剂治疗儿童过敏性哮喘和变应性鼻炎的临床评价[J].中华儿科杂志,2007,45(10):736-741.
[16]马香萍,多力坤.舌下特异性免疫治疗对尘螨过敏性哮喘儿童的作用[J].中国当代儿科杂志,2010,12(5):344-347.
[17]韩虹,陈少华,邱前辉.安脱达尘螨疫苗治疗变应性鼻炎的疗效及安全性评价[J].广东医学,2007,28(6):991-992.
[18]兰贵超,薛德厚,王美若,陈莉娜,卢丹.变应原检测和特异性免疫治疗中不良反应的分析[J].中华哮喘杂志,2009,3(1):22-25.